Emergent BioSolutions-backed Avectas has added $20m to its coffers to help drug developers create cancer treatments.

OSF Ventures invested $2m to bring the lung-imaging technology provider's latest round, which already included UnityPoint Health, to $13m.

The aeests of Intel Capital and Fitbit-backed glucose monitor developer have been acquired by diabetes-focused peer One Drop.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Disease diagnostics software provider Perspectum secured the return of Oxford and OSI to take its funding total to at least $41m.

The newly rebranded Blue Venture Fund co-led the round, which will support the commercialisation of Perspectum’s liver disease diganostics software.

NUI Maynooth spinout Avectas has added $20m to its coffers to develop cancer treatments.

GV and Takeda have backed a series B round that will fund the Rockefeller University spinout's identification of targets for brain disease treatments.

GV and returning investor Takeda Ventures chipped into a series B round that will fund the identification of targets for brain disease treatments.

MemorialCare Innovation Fund led a series B round featuring UnityPoint Health Ventures and OSF Ventures, taking SilverCloud's total funding past $30m.